g(m1)-ganglioside and Neuroleptic-Malignant-Syndrome

g(m1)-ganglioside has been researched along with Neuroleptic-Malignant-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for g(m1)-ganglioside and Neuroleptic-Malignant-Syndrome

Article	Year
Neuroleptic malignant syndrome and acute motor axonal neuropathy after Campylobacter jejuni infection. Neurophysiologie clinique = Clinical neurophysiology, 2009, Volume: 39, Issue:3 We report the case of a patient with Parkinson's disease who developed rapidly progressive weakness of the four limbs due to an acute motor axonal neuropathy (AMAN). This occurred days after a neuroleptic malignant syndrome (NMS). Serologic evidence of a preceding Campylobacter jejuni infection was detected and treatment with intravenous immunoglobulins proved effective. This case suggests that the rarely described neuropathies occurring with NMS may have a postinfectious immune basis and respond to immunomodulatory therapy. Topics: Antibodies, Bacterial; Antiparkinson Agents; Campylobacter Infections; Campylobacter jejuni; Electromyography; Fever; G(M1) Ganglioside; Guillain-Barre Syndrome; Humans; Immunoglobulin G; Immunoglobulin M; Immunoglobulins, Intravenous; Lipopolysaccharides; Male; Middle Aged; Molecular Mimicry; Neural Conduction; Neuroleptic Malignant Syndrome; Parkinson Disease; Quadriplegia; Unconsciousness	2009

Article

Year

Neuroleptic malignant syndrome and acute motor axonal neuropathy after Campylobacter jejuni infection.

Neurophysiologie clinique = Clinical neurophysiology, 2009, Volume: 39, Issue:3

We report the case of a patient with Parkinson's disease who developed rapidly progressive weakness of the four limbs due to an acute motor axonal neuropathy (AMAN). This occurred days after a neuroleptic malignant syndrome (NMS). Serologic evidence of a preceding Campylobacter jejuni infection was detected and treatment with intravenous immunoglobulins proved effective. This case suggests that the rarely described neuropathies occurring with NMS may have a postinfectious immune basis and respond to immunomodulatory therapy.

Topics: Antibodies, Bacterial; Antiparkinson Agents; Campylobacter Infections; Campylobacter jejuni; Electromyography; Fever; G(M1) Ganglioside; Guillain-Barre Syndrome; Humans; Immunoglobulin G; Immunoglobulin M; Immunoglobulins, Intravenous; Lipopolysaccharides; Male; Middle Aged; Molecular Mimicry; Neural Conduction; Neuroleptic Malignant Syndrome; Parkinson Disease; Quadriplegia; Unconsciousness

2009